R2D2-MH at a glance

Glossary

Consortium partners

advocacy groups

Countries

ACRONYM: R2D2-MH
Project title: Risk and Resilience in Developmental Diversity and Mental Health

Start Date: September 1, 2022

Project Duration: 60 months
EU contribution: € 7 856 503,75
Grant Agreement Number: 101057385
Coordinator: Prof. Thomas Bourgeron (Institut Pasteur, France)

R2D2-MH map with consortium partners

The R2D2-MH consortium gathers partners from thirteen different countries Worldwide: Belgium, Denmark, France, Germany, Ireland, Italy, Spain, Sweden, Switzerland, the United Kingdom, The Netherlands for the European continent, as well as Australia (upper box) and Israel (lower box).

Ambitions of the R2D2-MH project

R2D2-MH will go beyond the state of the art by applying a highly interdisciplinary approach allowing the participation of neurodivergent people and their families at all stages of the project. Giving neurodivergent people a voice through R2D2-MH is key to reducing stigma and ensuring that the results are truly translational. R2D2-MH also aims at a dual paradigm shift: from risk to resilience and from disorder to functioning, in a neurodiversity approach. Finally, R2D2-MH has the ambition to contribute to new clinical guidelines and policies via recommendations and white papers pointing out gaps, needs and actions necessary to improve mental health strategy in the EU.

R2D2-MH has four main ambitions to progress beyond the state of the art:

Triangle Square

Ambition 1

Increase participatory research/medicine and reduce stigma surrounding mental health

Ambition 3

Provide the largest European multi-scale dataset on early brain and mental health diversity in humans

Ambition 2

Co-develop a first generation of predictive models for developmental diversities (co-creation)

Ambition 4

Identify biological mechanisms of resilience associated with diverse outcomes in developmental diversities